Harel Insurance Investments & Financial Services Ltd. Beam Therapeutics Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$6.11 Billion
Q4 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 27, 2021	SELL	$71.28 - $120.75 $71,280 - $120,750	-1,000 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$22.24 - $95.63 $22,240 - $95,630	1,000 New	1,000 $263,000

Others Institutions Holding BEAM

# of Institutions

233

Shares Held

75.1M

Call Options Held

438K

Put Options Held

232K

Farallon Capital Management LLC San Francisco, CA

8.21M
Shares

$213 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

7.84M
Shares

$204 Million
0.0% of portfolio
Black Rock Inc. New York, NY

7.63M
Shares

$198 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

6.53M
Shares

$170 Million
1.52% of portfolio
Arch Venture Management, LLC Chicago, IL

4.83M
Shares

$126 Million
71.21% of portfolio

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.83B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account